CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that it has received notification from The NASDAQ Stock Market® that its common stock has been approved for listing on NASDAQ Global Market. The Company is currently going through all the required regulatory processes associated with the transition and expects its common stock to begin trading on NASDAQ under its new symbol IDRA on Monday, December 10, 2007. The Company’s common stock will continue to trade on the American Stock Exchange under its current symbol IDP until such time.
